Cargando…
Science review: Carnitine in the treatment of valproic acid-induced toxicity – what is the evidence?
Valproic acid (VPA) is a broad-spectrum antiepileptic drug and is usually well tolerated, but rare serious complications may occur in some patients receiving VPA chronically, including haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity (VHT) and VPA-induced hyperammonaemi...
Autores principales: | Lheureux, Philippe ER, Penaloza, Andrea, Zahir, Soheil, Gris, Mireille |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297603/ https://www.ncbi.nlm.nih.gov/pubmed/16277730 http://dx.doi.org/10.1186/cc3742 |
Ejemplares similares
-
Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide
por: Lheureux, Philippe ER, et al.
Publicado: (2005) -
Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers
por: Lheureux, Philippe ER, et al.
Publicado: (2006) -
Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
por: Chung, S., et al.
Publicado: (1997) -
Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis
por: Yokoyama, Saaya, et al.
Publicado: (2022) -
Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid
por: Ando, Masazumi, et al.
Publicado: (2017)